Prior to his appointment as CEO of Synaptive Medical in October 2017, Peter Wehrly was chairman of the Board of Directors and an advisor to the company. He is a former Group President at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). Peter held profit and loss responsibility for the marketing and sale of products for all of Covidien’s developed markets, Western Europe, Japanese, Australia-New Zealand between 2013 and 2015. He departed following the $42-billion sale of Covidien to Medtronic Inc. in 2015. Prior to this role, Peter was the president of Respiratory and Monitoring Solutions. Prior to Covidien, Peter held the position of Senior Vice-President of Medtronic’s Spinal and Biologics business. He started his career with DePuy Orthopaedics, a Johnson & Johnson company.